Home Our Business Units Formulations Overview Manufacturing capabilities
   
Manufacturing capabilities

Aurobindo has retained the same drive for growth that marked its early days. Starting off with a small SSP manufacturing unit in 1988, Aurobindo has grown to become the market leader in SSPs, non penicillins, cephalosporins, and non cephalosporins. In the global market, we believe in retaining our leadership in SSPs, cephalosporins, new anti-infectives and lifestyle disease drugs.

Our core strengths:

  • Vertically integrating the operations from conception to commercialization.
  • Larger manufacturing capabilities for a diversified product portfolio.
  • Efficient regulatory affairs team designed for market compliance.
  • Dedicated R&D setup for finished dosages and active ingredients.
  • Technology and expertise for specialty formulations

Our key formulation facilities (6 in India, 1 each in the US and Brazil):

Unit 3

  • An exclusive multi-product oral dosage form facility spread over 40,469 sq. meters for non cephalosporins and non beta-lactams
  • Spread over 40,469 sq. meters.
Unit 3

Unit 4

  • A dedicated manufacturing facility for generic sterile injectables (lyophilized and powder injections, prefilled syringes), opthalmics and low volume parenterals.
  • The facility is spread over 33 acres with a built-up area of 20,000 square. meters.
Unit 4

Unit 6

  • A dedicated facility spread over 58,060 square. meters for manufacturing oral and sterile cephalosporin formulations.
  • Spread over 58,060 sq. meters.
Unit 6

Unit 7

  • An ultra modern unit based on the suite manufacturing concept for huge capacities.
  • Manufactures non penicillins, non cephalosporins & ARVs
Unit 7

Unit 12

  • A dedicated facility spread over 15,228 square. meters.for manufacturing oral and sterile beta-lactam formulations.
  • Spread over 15,228 sq. meters.
Unit 12

Auronext

  • To produce sterile penem formulations.
  • Also manufactures sterile APIs
Auronext

Aurolife (Located in the US)

  • A 100,000 square feet state-of-the-art USFDA approved cGMP compliant manufacturing facility located in New Jersey
  • Manufactures non-pencillins and non-cephalosporin products
Aurolife

Brazil

  • Have an exclusive manufacturing facility for SSPs, which caters to the requirements of Latin America
Brazil